RNA5SP233: A Potential Drug Target and Biomarker (G100873491)

Target Name: RNA5SP233

NCBI ID: G100873491

RNA5SP233

Other Name(s): RNA, 5S ribosomal pseudogene 233 | RN5S233

RNA5SP233: A Potential Drug Target and Biomarker

RNA5SP233 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of cancer. RNA5SP233 has been shown to play a critical role in the regulation of cell proliferation, apoptosis, and angiogenesis, which are major factors in the development of cancer.

The discovery of RNA5SP233 as a potential drug target and biomarker has significant implications for the development of new cancer therapies. Targeting RNA5SP233 with small molecules or other therapeutic agents has the potential to inhibit its activity and reduce the growth and progression of cancer cells.

Expression of RNA5SP233

RNA5SP233 is a non-coding RNA molecule that is expressed in a variety of tissues and cells. It is primarily expressed in the brain, heart, and pancreas, and has also been found in other tissues such as the lungs, liver, and kidney. RNA5SP233 is usually expressed in a low level, but it can be highly expressed in certain conditions, such as when a cell is under stress or when it is undergoing apoptosis.

RNA5SP233 functions as a regulator of the cell cycle. It is involved in the G1, S, G2, and M phases of the cell cycle and helps to control the timing and progression of these phases. RNA5SP233 is also involved in the regulation of cell apoptosis, which is the process by which cells die when they have reached their lifespan.

RNA5SP233 has been shown to play a critical role in the regulation of cell proliferation. It has been shown to inhibit the activity of the oncogene badp3, which promotes the growth and proliferation of cancer cells. In addition, RNA5SP233 has been shown to promote the activity of the tumor suppressor gene p53, which helps to prevent the growth and proliferation of cancer cells.

RNA5SP233 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to the cells. RNA5SP233 has been shown to play a critical role in the regulation of angiogenesis and has been shown to be involved in the development of new blood vessels.

The Potential Role of RNA5SP233 as a Drug Target

The potential role of RNA5SP233 as a drug target is significant. RNA5SP233 has been shown to play a critical role in the regulation of cell proliferation, apoptosis, and angiogenesis, which are major factors in the development of cancer. Targeting RNA5SP233 with small molecules or other therapeutic agents has the potential to inhibit its activity and reduce the growth and progression of cancer cells.

RNA5SP233 has been shown to be involved in the development of various types of cancer, including breast, ovarian, and colorectal cancer. In addition, RNA5SP233 has been shown to be involved in the regulation of cancer cell metastasis, which is the process by which cancer cells spread to other parts of the body.

RNA5SP233 has also been shown to be involved in the regulation of the immune response, which is the process by which the body's immune system attacks and destroys cancer cells. In addition, RNA5SP233 has been shown to be involved in the regulation of the production of white blood cells, which are important for the immune response.

RNA5SP233 as a Biomarker

RNA5SP233 has also been shown to be a potential biomarker for cancer. The expression of RNA5SP233 has

Protein Name: RNA, 5S Ribosomal Pseudogene 233

The "RNA5SP233 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP233 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets